Breast Cancer: Early Detection, Screening, and Treatment in Sangareddy
Expert Oncology (Cancer Care) care at KBR Life Care Hospitals, Sangareddy
Breast Cancer: Early Detection, Screening, and Treatment in Sangareddy
Breast cancer is the most commonly diagnosed cancer among women in India, and like most cancers, its outcomes depend enormously on when it is found. Detected at an early stage, before it has spread beyond the breast, breast cancer is highly treatable and often curable. Detected late, after symptoms have been present for months without evaluation, the options narrow significantly.
At KBR Life Care Hospitals, Sangareddy, we want every woman in our region to know that noticing a change in your breast and seeking an evaluation is an act of strength, not something to delay out of fear or hesitation. Our team creates a comfortable, confidential space for breast health concerns. We provide clinical breast examination, guide you through the appropriate investigations, explain what findings mean in plain language, and ensure you are supported at every step.
For women already diagnosed with breast cancer, we coordinate with oncology specialists to map out a clear, evidence-based treatment plan. You do not need to navigate this alone, and you do not need to travel far from Sangareddy for expert guidance.
Types & Causes
Invasive Ductal Carcinoma (IDC)
The most common type, accounting for about 70-80% of breast cancers; starts in the milk ducts and grows into surrounding breast tissue
Invasive Lobular Carcinoma (ILC)
Starts in the lobules (milk-producing glands); can be harder to detect on imaging as it spreads in a diffuse pattern
Ductal Carcinoma In Situ (DCIS)
An early, non-invasive cancer confined within the duct; highly treatable and has not yet spread to surrounding tissue
Hormone Receptor-Positive Breast Cancer
Cancer cells grow in response to oestrogen or progesterone; responds well to hormone-blocking therapies in addition to standard treatment
HER2-Positive Breast Cancer
Overexpresses the HER2 protein; tends to grow faster but responds well to targeted HER2 therapies
Triple-Negative Breast Cancer
Does not respond to hormone or HER2 therapies; primarily treated with chemotherapy and surgery
Symptoms to Watch For
A new lump or thickening in the breast or underarm area
Change in breast size, shape, or contour
Skin dimpling, puckering, or an orange-peel texture on the breast
Nipple turning inward (inversion) when this is new
Nipple discharge, particularly if bloody or from one breast only
Redness, scaling, or crusting of the nipple or breast skin
Persistent breast pain that is new and unexplained
Swollen lymph nodes in the armpit
When to See a Doctor
- Any new breast lump or thickening, even if painless
- Any change in breast appearance, skin texture, or nipple
- Bloody or unexplained nipple discharge
- A breast lump that does not change with the menstrual cycle
- Personal or family history of breast or ovarian cancer: discuss a screening plan proactively
- You are 40 years or older and have not had a recent clinical breast examination
How We Diagnose
- Clinical breast examination by a trained doctor
- Ultrasound of the breast: the first-line imaging for women under 40 and for evaluating lumps
- Mammogram: recommended for women over 40 and as part of screening programmes
- Core needle biopsy or fine needle aspiration (FNA) to obtain tissue for analysis when a suspicious lesion is found
- Hormone receptor and HER2 testing on biopsy tissue to guide treatment selection
- Staging investigations (CT, bone scan) when breast cancer is confirmed to assess spread
Our Treatment Approach
- Surgery: lumpectomy (breast-conserving) or mastectomy depending on tumour size, location, and patient preference
- Radiation therapy: typically follows breast-conserving surgery to reduce local recurrence risk
- Chemotherapy: used before surgery (neoadjuvant) to shrink tumours or after surgery (adjuvant) to reduce recurrence risk
- Hormone therapy: anti-oestrogen drugs (tamoxifen, aromatase inhibitors) for hormone receptor-positive cancers
- Targeted therapy: HER2-directed agents for HER2-positive cancers
- Regular follow-up with clinical examination and imaging to monitor for recurrence
Why Choose KBR Life Care Hospitals?
Frequently Asked Questions
Get answers to common questions about this specialty
Ready to Consult Our Oncology (Cancer Care) Experts?
Take the first step towards better health. Our experienced team at KBR Life Care Hospitals, Sangareddy is here to provide you with the best care possible.